Clinical Trials Directory

Trials / Conditions / Large B-Cell Lymphoma (LBCL)

Large B-Cell Lymphoma (LBCL)

8 registered clinical trials studyying Large B-Cell Lymphoma (LBCL) — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingExploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relaps
NCT07447726
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1 / Phase 2
Not Yet RecruitingThe Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL
NCT07514169
Ruijin HospitalPhase 2
Not Yet RecruitingInvestigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Pat
NCT07361224
Tel-Aviv Sourasky Medical CenterPhase 1
Not Yet RecruitingGolcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT07269639
Seoul National University HospitalPhase 1 / Phase 2
RecruitingSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793
AstraZenecaPhase 2
RecruitingCD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma
NCT07461831
Beijing Tongren HospitalPhase 2
RecruitingReal World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell Lymphoma
NCT07524816
N.N. Alexandrov National Cancer Centre—
RecruitingCD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma
NCT04661020
Zhejiang UniversityPhase 2